-
Mashup Score: 2SLE Faculty Panel Q&A | RheumNow - 3 day(s) ago
SLE Faculty Panel Q&A – Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22Complex Autoantibody Patterns in RA | RheumNow - 3 day(s) ago
Patients with rheumatoid arthritis (RA) all have a unique and diverse set of antibodies that are involved in the development of the disease. Researchers at Utrecht University unveiled the complexity of these antibodies using powerful lab tools capable of analysing our immune system at molecular levels. This discovery reported in Nature Communicationssuggests that current assumptions about the origin of RA are too simple. Still, their findings may point towards improved diagnostics.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Systemic Inflammation and Mortality in RA-ILD | RheumNow - 3 day(s) ago
Analysis of the German RABBIT registry shows that systemic inflammation, more so than disease activity, strongly influences all-cause mortality in patients with rheumatoid arthritis and prevalent interstitial lung disease (RA-ILD).RA-ILD patients from the biologics register Rheumatoid Arthritis: Observation of Biologic Therapy (RABBIT) were enrolled to assess the down stream effects of disease activity, disease-modifying antirheumatic drugs (DMARDs).
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 7
Watch our videos featuring global rheumatology experts to learn about recent advances towards slowing organ damage progression in lupus. Discover how you can implement disease modification and remission treatment goals, alongside corticosteroid tapering and the earlier introduction of biologics, to help improve patient outcomes.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 11
AbstractObjectives. To assess the frequency and characteristics of severe relapse in patients with GCA in a real-life setting.Methods. In a monocentric dat
Source: academic.oup.comCategories: General Medicine News, RheumatologyTweet-
In 530 #GCA pts, relapses seen in 46%; but severe relapse (ischemi/aortic events) in 3%. Severe GCA relapse pts more likely to be younger at Dx(P=0.02), w/ more limb claudication(< 0.0001), fewer GCA-related cranial Sxs (<0.0001); but not higher mortality https://t.co/k7wgU6oMcn https://t.co/BKOfGmZ27u
-
-
Mashup Score: 26
FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines.
Source: www.fda.govCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11
Full Papers; Authors: X. Li, C. Ma, J. Xu, M. Zhang, Q. Xiang, Y. Li, W. Li, P. Zhu
Source: www.clinexprheumatol.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 31Biomarker Predictors of Osteoarthritis | RheumNow - 4 day(s) ago
Science Advances has reported that Duke University researchers have validated a biomarkers of osteoarthritis that may be identified 2 years before the appearance of radiographic OA. Six peptides (biomarker) demonstrated an AUC 77% probability of successfully predicting knee osteoarthritis at least eight years before OA was evident on x-rays, Duke Health researchers report.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 29
AbstractBackground/Aims. Age has a significant impact on SLE. However, data on very late onset SLE (vlSLE) patients are scarce. We have characterized a lar
Source: academic.oup.comCategories: General Medicine News, General HCPsTweet-
Very late onset Lupus (>60) is less female, less arthritis/dz activity, lower dsDNA, C3, SSA, SSB and ANA but more Sjogrens & RA? Single clinic study of 845 SLE - jSLE (<18), aSLE (18-49), lSLE (50-60), and vlSLE (>60).vlSLE had lowest survival (20yrs) https://t.co/VwDSArDhrc https://t.co/3pSr0xSCKn
-
-
Mashup Score: 7British Societies Develop First 'Living' Behçet Guidelines - 5 day(s) ago
The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Behçet’s disease.
Source: www.medscape.comCategories: General Medicine News, RheumatologyTweet
SLE Faculty Panel Q&A https://t.co/2OWlhfmKaP https://t.co/jx6MPDtojS